Can a vibrating platform steady the wobbly joints of hypermobility?
NCT ID NCT07830589
First seen Sep 21, 2026 · Last updated Sep 21, 2026
Summary
Researchers are testing whether adding whole-body vibration to a standard exercise program improves balance and reduces pain in women with hypermobility spectrum disorder. Thirty women aged 18 to 45 who have had musculoskeletal pain for at least three months join either a supervised exercise program alone or the same program plus vibration platform sessions. Both groups exercise for six weeks, and the team measures changes in dynamic balance and pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- whole-body vibration exercise on a Power Plate platform added to a conventional exercise program
- What this could lead to
- If it helps, whole-body vibration could become a low-cost add-on to standard exercise therapy for balance problems in people with hypermobility spectrum disorder.
- What could go wrong
- This is a small, short trial of 30 women, so any benefit may be modest or fade after the six-week program ends. Vibration platforms are not safe for people with pacemakers or metal implants, and the results may not apply to men or other age groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Diagnosis of hypermobility spectrum disorder (Beighton score ≥4/9) Female participants aged 18-45 years Presence of musculoskeletal pain for at least 3 months Exclusion Criteria: Pregnancy Presence of a cardiac pacemaker Presence of an implanted brain stimulator Presence of a metal implant Acute or chronic arthritis Active malignancy Acute infection Initiation of medications that may affect proprioception or postural stability (e.g., antidepressants, antipsychotics, or hypnotics) within the previous 2 months Regular exercise more than 3 days per week Postmenopausal status Orthopedic surgery within the previous 12 months Vertigo Acute painful conditions that would prevent participation in exercise
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypermobility spectrum disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koç University Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.